|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
J. Biol. Chem., Vol. 281, Issue 23, 15662-15670, June 9, 2006
Arabidopsis thaliana VTC4 Encodes L-Galactose-1-P Phosphatase, a Plant Ascorbic Acid Biosynthetic Enzyme* 1 2 3![]() ![]() ![]() ![]() ![]() 4
From the
Received for publication, February 14, 2006 , and in revised form, March 28, 2006.
In plants, a proposed ascorbate (vitamin C) biosynthesis pathway occurs via GDP-D-mannose (GDP-D-Man), GDP-L-galactose (GDP-L-Gal), and L-galactose. However, the steps involved in the synthesis of L-Gal from GDP-L-Gal in planta are not fully characterized. Here we present evidence for an in vivo role for L-Gal-1-P phosphatase in plant ascorbate biosynthesis. We have characterized a low ascorbate mutant (vtc4-1) of Arabidopsis thaliana, which exhibits decreased ascorbate biosynthesis. Genetic mapping and sequencing of the VTC4 locus identified a mutation (P92L) in a gene with predicted L-Gal-1-P phosphatase activity (At3g02870). Pro-92 is within a -bulge that is conserved in related myo-inositol monophosphatases. The mutation is predicted to disrupt the positioning of catalytic amino acid residues within the active site. Accordingly, L-Gal-1-P phosphatase activity in vtc4-1 was 50% of wild-type plants. In addition, vtc4-1 plants incorporate significantly more radiolabel from [2-3H]Man into L-galactosyl residues suggesting that the mutation increases the availability of GDP-L-Gal for polysaccharide synthesis. Finally, a homozygous T-DNA insertion line, which lacks a functional At3g02870 gene product, is also ascorbate-deficient (50% of wild type) and deficient in L-Gal-1-P phosphatase activity. Genetic complementation tests revealed that the insertion mutant and VTC4-1 are alleles of the same genetic locus. The significantly lower ascorbate and perturbed L-Gal metabolism in vtc4-1 and the T-DNA insertion mutant indicate that L-Gal-1-P phosphatase plays a role in plant ascorbate biosynthesis. The presence of ascorbate in the T-DNA insertion mutant suggests there is a bypass to this enzyme or that other pathways also contribute to ascorbate biosynthesis.
L-Ascorbic acid (vitamin C) has been the subject of much research from the time it was first identified as the anti-scorbutic factor (1, 2). It is used as a cofactor by a number of enzymes (3), but it is perhaps better known for its role as an antioxidant. Many different organisms make use of ascorbate to detoxify the variety of reactive oxygen species (ROS5; O2, , H2O2, and HO·) that are generated as a result of an aerobic life-style. One electron can be donated from ascorbate, forming monodehydroascorbate (ascorbate-free radical), whereas donation of a second electron results in production of the fully oxidized dehydroascorbate (4). Both plants and animals possess monodehydroascorbate and dehydroascorbate reductases to recycle the oxidized forms back to ascorbate (5).
Ascorbate is highly abundant in plant tissues, with concentrations in the 120 mM range, and not surprisingly has a major function in the maintenance of ROS homeostasis. ROS are formed as by-products of a variety of physiological processes, including the
Ascorbate-deficient Arabidopsis thaliana mutants representing four different loci have been described that are valuable tools in the understanding of the physiological roles of ascorbate. The first of these mutants, vtc1-1 (vitamin c 1), was isolated in a screen for ozone-sensitive mutants (7) and contains
In addition to the utility of vtc1-1 mutant as an aid in the functional analysis of ascorbate, it has also proven invaluable as a genetic tool in the study of ascorbic acid biosynthesis in plants. In 1998, a novel plant ascorbic acid biosynthetic pathway was proposed in which L-Gal is oxidized sequentially to L-galactono-1,4-lactone and ascorbate (15, 16) (Fig. 1). The newly proposed pathway resolved a puzzle regarding the source of substrate for the previously well characterized plant L-galactono-1,4-lactone dehydrogenase (15). Radiolabeling studies showed that L-Gal is derived from GDP-Man (15). Functional in planta evidence for this pathway was provided by the VTC1 gene, which encodes GDP-Man pyrophosphorylase and forms GDP-Man from Man-1-P (Fig. 1) (17). The vtc1-1 mutant has a point mutation in this gene, lowered activity of this enzyme, and is ascorbate-deficient. In addition to the GDP-Man pyrophosphorylase gene, the genes encoding GDP-Man 3'',5''-epimerase, L-galactono-1,4-lactone dehydrogenase, and the L-Gal dehydrogenase have also been identified (1820). GDP-Man 3'', 5''-epimerase converts GDP-Man to GDP-L-Gal, which is then proposed to be broken down in two steps to L-Gal (Fig. 1, steps 3 and 4). Additionally, it has been shown that GDP-L-gulose is also produced as a result of GDP-Man 3'', 5''-epimerase activity and could be converted to ascorbate via L-gulonolactone (Fig. 1) (21). Reduction of L-Gal dehydrogenase and L-galactono-1, 4-lactone dehydrogenase activities in planta (via anti-sense suppression) leads to reduced levels of ascorbate (18, 22). Recently, a gene encoding an enzyme with L-Gal-1-P phosphatase activity was identified in kiwi fruit and A. thaliana (23). This enzyme is predicted to take part in ascorbate biosynthesis (Fig. 1, step 4). As described below, we have found that the ascorbate-deficient A. thaliana vtc4-1 mutant harbors a defect in the same L-Gal-1-P phosphatase gene, providing genetic evidence for the role of this enzyme in plant ascorbate biosynthesis.
Measurement of Ascorbate ContentAcidic extracts were prepared from whole rosettes of 3-week-old vtc4-1 (backcross 2 generation; BC2) and WT ecotype Columbia-0 for the assay of the total and reduced ascorbate as described previously (7, 24). At least three whole rosettes were used in each extract, and the average ascorbate (total and reduced) content from five extracts/genotype was determined. The plants used for these assays were grown with a 16-h photoperiod under metal halide bulbs in a commercial soil-less mix (Promix BX; Premier Horticulture Inc., Quakertown, PA). For the assay of total ascorbate in WT, vtc4-1 BC2, insertion line KO-1, insertion line KO-2, F1 (vtc4-1 x KO-1), F1 (vtc4-1 x KO-2), expanded leaves from at least three different 2-week-old rosettes were utilized for each extract, and the average total ascorbate was determined from three extracts/genotype. The plants used for these assays were grown in an environmental growth chamber (Percival AR36L3) under a 24-h photoperiod at 21 °C with 70% relative humidity under fluorescent bulbs at 150 µmol s1 m2 photosynthetic photon flux density.
Fine-scale Genetic Mapping of the VTC4 LocusThe VTC4 locus was found to be located Sequencing of the VTC4 LocusTotal DNA was isolated from vtc4-1 (BC2) and Columbia-0 WT using a cetyltrimethylammonium bromide mini-prep method as described previously (25). The VTC4 locus was amplified from these DNAs using two PCR primer pairs (Sigma Genosys, The Woodlands, TX) that together amplified the VTC4 candidate gene (At3g02870). One set of primers (F, 5'-CGTTGGGACTGGCTGTATC-3'; R, 5'-AAACAACTCCAACAACAGGG-3') amplified a 2036-bp product, including 1193 bp upstream of the ATG start codon. A second set of primers (F, 5'-CCAATTTCGTTCACGGGTAT-3';R, 5'-GGACAACAGTCACCGTGAGA-3') amplified a 1749-bp overlapping product that included 488 bp 3' of the stop codon. Sequencing primers nested within these two products (and in some cases, single PCR primers) were used to obtain genomic sequence from vtc4-1 that spanned from 715 bases upstream of the putative 5'-transcript terminus to 192 bp downstream of the putative 3'-transcript terminus (Biotechnology Resource Center, Cornell University, Ithaca, NY). Both strands of vtc4-1 DNA were sequenced in the region of the mutation. One strand of WT Columbia-0 DNA was sequenced in this same region to verify the published WT genomic sequence.
Identification of Homozygous Insertion Mutant at the VTC4 LocusSegregating T3 generation seed for the SAIL_8443_G10 sequence indexed insertion line (26) was obtained from the Arabidopsis Biological Resource Center. Total DNA was isolated from 16 individual plants as described above. The VTC4 locus was amplified from these DNAs using the second set of (flanking) primers described above. Those individual lines that did not yield a PCR product with these VTC4 WT allele-specific primers were then each amplified in a series of two separate PCRs using the insertion primer LB1 (5'-GCCTTTTCAGAAATGGATAAATAGCC TTGCTTCC-3') and either the F or R flanking primers. Five homozygous insertion individuals and six heterozygous individuals were identified using this series of amplification reactions. To confirm the site of the insertion, the To confirm the genotypes of the F1 (vtc4-1 x KO-1) and F1 (vtc4-1 x KO-2) individuals, DNA was extracted from at least five F1 plants derived from each cross as described above and genotyped by PCR in two separate reactions/genotype (along with WT, vtc4-1, KO-1 T4, and KO-2 T4 DNAs as controls) using the VTC4 flanking F and R primers in one reaction (noninsertion allele specific product) and the VTC4 R and LB1 primers in a second reaction (insertion allele-specific product). RNA Extraction and RT-PCRFor the semi-quantitative assay of transcript levels in vtc4-1 in comparison with WT, the following protocol was utilized. Total RNA was isolated from Arabidopsis leaves collected just prior to flowering using an RNeasy plant RNA kit (Qiagen, Crawley, UK) and treated with DNase (Qiagen, Crawley, UK) according to the manufacturer's instructions. Synthesis of cDNA was carried out, using 5 µg of total RNA as template, with random primers (RETRO-script, Ambion, Huntingdon, UK) and Superscript II (Invitrogen). Semi-quantitative PCR, using the cDNA as template, was performed using an 18S Competimer system (Ambion, Huntingdon, UK) according to the manufacturer's instructions. Primers used in the PCR were 5'-GGAAAGGAGCATTCTTGAATGG-3' and 5'-CAACGCCTCAGCGAATAAC-3' and the cycling parameters consisted of 2 cycles (96 °C 1 min, 50 °C 30 s, and 72 °C 1 min) followed by 32 cycles (92 °C 25 s, 54 °C 30 s, and 72 °C 1 min) and a 10-min extension at 72 °C. For the assay of the presence/absence of transcript in WT, versus the insertion lines KO-1 and KO-2, total RNA was isolated from 100 mg of Arabidopsis leaves collected from plants 20 days of age that were grown in an environmental growth chamber (Percival AR36L3) under the same conditions as the plants utilized for the total ascorbate assays described above. The RNA was isolated using the RNeasy plant mini kit (Qiagen, Crawley, UK). Synthesis of cDNA was carried out using 1 µgof total RNA as the template, with the VTC4RTR 5'-CAACGCCTCAGCGAATAAC-3', the UBQ10R 5'-CGACTTGTCATTAGAAAGAAAGAGATAACAGC-3', and ferredoxin-nitrite reductase R 5'-CCACGGATCTGCCAATTCTGT-3' gene-specific primers and Moloney murine leukemia virus RT (Promega Corp., Madison, WI). Nonquantitative PCRs were then performed using the above cDNAs as templates and the following primers in addition to the reverse primers listed above: VTC4RTF 5'-GGAAAGGAGCATTCTTGAATGG-3, UBQ10F 5', UBQF 5'-GATCTTTGCCGGAAAACAATTGGAGGATGG-3', and ferredoxin-nitrite reductase F 5'-TCCGGTTCCACCTGCCAACA-3'. Cycling parameters consisted of 1 cycle (95 °C 3 min) followed by 40 cycles (94 °C 20 s, 54 °C (VTC4RTF/R and ferredoxin-nitrate reductase F/R) or 58 °C (UBQFR) 20 s, 72 °C 1 min) and a 5-min extension at 72 °C. Ascorbate Biosynthesis from [U-14C]Man and [1-14C]Ascorbate MetabolismD-[U-14C]Man (1 µCi per sample, specific activity 290 mCi mmol1; Amersham Biosciences) or [1-14C]ascorbate (27) was supplied via the petiole to whole excised Arabidopsis leaves from 6-week-old plants. Following radiolabel nated uptake (1 h), leaves were illumi-(6070 µmol m2s1 photosynthetic photon flux density) in sealed Perspex boxes for 4 h. Leaves were rinsed thoroughly prior to perchloric acid extraction and determination of incorporation of [14C]ascorbate and other fractions as described previously (24). Briefly, leaf tissue was ground in liquid nitrogen, homogenized in 1 ml of 5% perchloric acid, 1 mM EDTA, and centrifuged (12,000 x g, 2 min, 4 °C). The supernatant was neutralized by the addition of 60 µlof5 M potassium carbonate and centrifuged again (12,000 x g, 2 min, 4 °C). The ascorbate concentration in the resultant supernatant was determined by the ascorbate oxidase method (24), prior to ion exchange fractionation. This allowed determination of the recovery of ascorbate after ion exchange and HPLC separation. The resultant supernatant was mixed with an equal volume of 10% dithiothreitol (DTT) and fractionated by ion exchange chromatography (SAX column, HPLC Technology, Macclesfield, UK). Ascorbate was eluted from the column with 60 mM formic acid. The eluent was immediately frozen in liquid nitrogen and lyophilized. Samples were reconstituted in 6 mM formic acid and loaded onto a Rezex ROA HPLC column (Phenomenex, Macclesfield, UK) using a mobile phase of 0.75 mM sulfuric acid (0.5 ml min1). Ascorbate was detected by UV absorbance at 260 nm. The identity of the ascorbate peak was confirmed in preliminary experiments by treatment of the samples with ascorbate oxidase. This removed the peak detected by HPLC at 260 and 210 nm. Radioactivity in the eluent fractions corresponding to ascorbate was determined by liquid scintillation counting. The rate of turnover of ascorbate was calculated from [1-14C]ascorbate metabolism as described previously (27). Incorporation of D-[2-3H]Man into PolysaccharidesD-[2-3H]Man (25 µCi, specific activity 1020 Ci/mmol) (Amersham Biosciences) was supplied to small expanding leaves from young Arabidopsis plants (23 weeks old) via their petioles. Following uptake of the radiolabel (2 h), leaves were illuminated (6070 µmol m2 s1 photosynthetic photon flux density) in sealed Perspex boxes for 4 h. Samples were then rinsed thoroughly prior to homogenization in ice-cold 80% ethanol. Insoluble material was collected by centrifugation (12,000 x g, 2 min) and washed three times with 80% ethanol. Polysaccharides and oligo-saccharides associated with glycoproteins in this material were hydrolyzed by incubation with 2 M trifluoroacetic acid at 110 °C for 1 h (28). Nonhydrolyzed material was removed by centrifugation (12,000 x g, 2 min), and trifluoroacetic acid was removed from the supernatant by evaporation. Monosaccharides were separated by TLC (29). Separation was performed by an acetone/butanol/water solvent (8:1:1 v/v) on silica gel TLC plates (Whatman) pre-soaked in 0.3 M sodium dihydrogen orthophosphate and then dried. The radioactivity was detected by a Berthold LB2832 Linear Analyser (Wildbad, Germany). Radioactive peaks were identified by co-chromatography with authentic standards. D-Gal was removed by treatment with D-Gal dehydrogenase (from Pseudomonas fluorescens, Sigma). The reaction mixture contained 0.1 unit of D-Gal dehydrogenase and a 10-µl sample in 175 µl of 50 mM Tris-HCl, pH 8.6, containing 7 mM NAD+ and was incubated for 16 h. Samples were then deionized by ion exchange chromatography to facilitate TLC analysis. This technique fully resolves L-Fuc, L-Gal, and D-Man, but L-Gul is not resolved from D-Man. Assay of L-Gal-1-P PhosphataseRosette leaves from plants just prior to flowering, grown under a 16-h light period at 150 mmol s1 m2 photosynthetic photon flux density (20 °C during light period, 15 °C during dark period), were homogenized in 50 mM Hepes, pH 7.5, 10 mM MgCl2, 2 mM DTT, 1 mM aminocaproic acid, 1 mM benzamidine, 1 mM phenylmethylsulfonyl fluoride (5 g of tissue, 10 ml of extract). Duplicate extracts were made for each experiment, and the experiments were repeated on two occasions with identical results. Tissue debris was filtered off, and the homogenate was centrifuged at 20,000 x g for 20 min at 4 °C. Ammonium sulfate was added to the supernatant to 40% saturation, and precipitated protein was pelleted by centrifugation as before for 30 min. The supernatant was collected and ammonium sulfate added to give 60% saturation. After centrifugation, the pelleted protein was recovered. This was dissolved in 25 mM Tris-HCl, pH 7.5, containing 1 mM DTT. L-Gal-1-P phosphatase activity was determined by incubating a 10-µl sample with 80 µl of 50 mM Tris-HCl, pH 7.5, containing 0.1 mM L-Gal-1-P and 3 mM MgCl2 for 1 h. The reaction mixture was then boiled for 2 min and centrifuged at 12,000 x g for 2 min. L-Fucose (L-Fuc; 0.05 mM final concentration) was added as an internal standard. The sugars in 20 µl of this sample were separated and quantified using a Dionex DX600 LC with a CarboPac PA-10 column and electrochemical detection. The mobile phase was 18 mM NaOH at 1 ml min1, and the column was washed with 200 mM NaOH between samples. The ED50 electrochemical detector was equipped with a gold electrode and was operated in pulsed amperometric mode specific for sugars (waveform: 0sat 0.05 V, 0.2 s at 0.05 V (integration on) 0.4 s at 0.05 V (integration off) 0.41 s at 0.075 V, 0.6 s at 0.75 V, 0.61 s at 0.15 V, 1.00 s at 0.15 V). The L-Gal-1-P was a gift from J. Thiem (University of Hamburg, Germany).
Decreased Ascorbate Synthesis from Man in vtc4As described previously (11), the A. thaliana mutant vtc4-1 (vitamin C 4) was isolated in a nitro blue tetrazolium-based screen for ascorbic acid-deficient ethane methyl sulfonate-generated mutants of the Columbia-0 ecotype. VTC4 is one of four VTC loci identified by this screen (6). At 3 weeks of age, the homozygous vtc4-1 mutant contains 42% of the total ascorbate found in WT plants (Fig. 2A). Although deficient in total ascorbate, the redox status of vtc4-1 (the ratio of total to reduced ascorbate) does not significantly differ from that of WT (Fig. 2B). Both genotypes maintain a highly reduced pool of ascorbate ( 88% for WT and 85% for vtc4-1). Radiolabeling experiments were carried out to determine whether the low ascorbate content of vtc4 is caused by slower biosynthesis via the D-Man pathway or by faster catabolism. Leaves were labeled with D-[14C]Man, extracted, and fractionated into soluble and insoluble compounds and CO2. Ascorbate was separated by HPLC and its 14C content determined. 30% less14C was incorporated into ascorbate in vtc1 compared with WT, whereas the distribution of label in other fractions did not differ (Table 1). This compares closely to the 42% reduction in ascorbate content. Feeding [14C]ascorbate and determining the transfer of 14C to other compounds estimated ascorbate turnover (27). The turnover of ascorbate in vtc4-1 under these conditions was 0.63 ± 0.06 µ mol 5 h1 g1 fresh weight, compared with 0.72 ± 0.1 µmol 5 h1 g1 fresh weight in wild type. These results suggest that low ascorbate in vtc4-1 is caused by a slower rate of biosynthesis from D-Man.
Genetic Evidence That VTC4 Encodes L-Gal-1-P Phosphatase and That This Enzyme Is Involved in Ascorbate BiosynthesisThe VTC4 locus was initially mapped to the top of chromosome III, 2-centimorgan centromeres distal from the microsatellite marker nga172 (Fig. 3A) (11), which is located at 6.91 centimorgans. By using a mapping population of 1772 F2 individuals derived from a cross between vtc4-1 and the wild-type Ler ecotype, the VTC4 locus was narrowed genetically to the region between insertion/deletion CER469590 (70,34570,358 bp) on BAC F13E7 and single nucleotide polymorphism CER467138-140 (26,03226,203 bp) on the 100-kb BAC F13E7 (Fig. 3B). The centromere distal recombination breakpoint was defined by two recombinants, whereas the centromere proximal breakpoint was defined by three recombinants. This region spans 44 kb and contains 12 candidate genes (Fig. 3C).
One of the 12 candidate VTC4 genes (At3g02870) has been annotated as encoding a myo-inositol monophosphatase-like protein (TAIR; see Ref. 30). However, Laing et al. (23) recently published evidence demonstrating that this gene (and its homologue in kiwi fruit) encodes an enzyme with L-Gal-1-P phosphatase activity in vitro and upon expression in Escherichia coli.As L-Gal-1-P phosphatase is predicted to play a role in the D-Man/L-Gal ascorbic acid biosynthetic pathway (15, 23) catalyzing the conversion of L-Gal-1-P to L-Gal (Fig. 1), we sequenced At3g02870 in vtc4-1. Indeed, vtc4-1 harbors a cytosine to thymine point mutation within exon 5 at nucleotide +275 relative to the first nucleotide of the predicted methionine start codon (Fig. 3D). As this mutant was generated by ethane methyl sulfonate, a C/G to T/A transition mutation was not unexpected. The transcript abundance of the L-Gal-1-P phosphatase mRNA in vtc4-1 and WT leaves, just prior to flowering, was determined with RT-PCR. The abundance of L-Gal-1-P phosphatase-specific mRNA is quite low in both genotypes but is not significantly lower in the mutant (data not shown).
The predicted VTC4 (At3g02870) gene product belongs to a group of polypeptides with a conserved domain defined by the HomoloGene system of the NCBI (cd01639). This conserved domain group includes primarily members of the inositol monophosphatase (IMPase) family of genes. IMPases function as homodimers. Many of these members utilize inositol monophosphate as a substrate, but some have phosphatase activity toward other substrates such as fructose 1,6-bisphosphate (31). The cd01639 group all encode either predicted or experimentally confirmed Mg2+-dependent phosphatases that are inhibited by lithium. The L-Gal-1-P phosphatase activity encoded by Actinidia deliciosa, and the Arabidopsis enzyme encoded by At3g020870, is completely dependent in vitro on Mg2+ for activity, and furthermore, the A. deliciosa enzyme is inhibited strongly by lithium (23). A highly conserved domain shared by this group is composed of six amino acids. An amino acid alignment of the region containing this domain in representatives from cd01639 is shown (Fig. 4). The VTC4 protein structure has been modeled using the Swiss model homology model server (32) using the known three-dimensional structures of several inositol phosphatase enzymes, with which VTC4 shares 4041% sequence identity (3335). The resulting model was compared with the structure of human inositol phosphatase containing the substrate D-myo-inositol 1-phosphate (36) (Protein Data Bank code 1IMB). Most structural features of substrate- and metal-binding sites are conserved between the x-ray structure and the VTC4 model. The residue Pro-92 is located on a stretch of about 30 residues with high sequence conservation that spans through
To confirm the predicted effect of the mutation on L-Gal-1-P phosphatase activity, phosphatase activity was measured in the 4565% saturation ammonium sulfate fraction of WT and vtc4-1 leaf extracts. This fraction is enriched in L-Gal-1-P phosphatase activity assayed at pH 7.5 (see below). In each of two replicate assays, the phosphatase activity with the substrate L-Gal-1-P was reduced 2-fold in vtc4-1 (Fig. 5A). The specificity of this difference was confirmed by comparing the phosphatase activity toward a variety of sugar phosphates. There was no difference in the rate of hydrolysis of Glc-1-P, Glc-6-P, and Fru-6-P. Man-1-P was hydrolyzed more rapidly by WT extracts; however, this difference was much less marked than for L-Gal-1-P (Fig. 5B).
D-Mannose and L-Galactose Metabolism Are Affected in vtc4-1The metabolism of mannose in vtc4-1 and WT leaves was examined in more detail. As vtc4-1 is impaired in L-Gal-1-P phosphatase activity, we predicted that intermediates upstream of this block in the ascorbate biosynthetic pathway might accumulate. As both GDP-D-Man and GDP-L-Gal are precursors for polysaccharides, we examined the incorporation of D-mannose into polysaccharides in WT and vtc4-1 leaves. D-[2-3H]Man was fed to intact leaves, and the monosaccharide residues released following trifluoroacetic acid hydrolysis of the 80% ethanol-insoluble fraction (primarily cell wall) were determined by TLC. Radioactivity was detected in L-Gal, D-Man, and L-Fuc. In two independent experiments, the proportion of the radiolabel recovered in L-Gal residues from vtc4-1 leaves was greater than the recovery from wild type. 24 and 28% of total hydrolyzable radioactivity was recovered as L-Gal from vtc4-1, compared with recoveries of 11 and 12% from wild-type leaves (Fig. 6). It is possible that other labeled sugars co-chromatograph with L-Gal, thus invalidating this conclusion. However, several lines of evidence suggest this possibility is unlikely. First, radiolabel appearing in L-Gal is derived directly from D-[2-3H]Man because the label is lost from C-2 if D-Man is first converted to Glc by a C-2 epimerization (38). Therefore, only sugars derived directly from D-Man could be labeled. These include L-Gul, which co-chromatographs with D-Man, and 4-keto-6-deoxy-D-mannose, which is an intermediate of GDP-L-Fuc synthesis (39) and will not occur in polysaccharides. Second, Roberts (40), using a similar chromatographic technique, demonstrated that radiolabeled L-Gal residues derived from D-Man in maize roots did not co-chromatograph with detectable quantities of any other monosaccharide after multiple recrystallizations of the L-Gal methylphenylhydrazone derivative. Third, other glycosyl residues found in plant polysaccharides (e.g. D-Glc, D-Gal, xylose, arabinose, apiose, and rhamnose) are derived from UDP-Glc (41) and will not be labeled. Any possible interfering labeled D-Gal was specifically removed by treatment with D-Gal dehydrogenase. Phenotype of Plants Homozygous for an Insertion Mutation in the VTC4 LocusTo confirm that VTC4 = At3g02870, we isolated and analyzed an Arabidopsis line homozygous for an insertion allele of At3g02870. A population of 16 individual plants of the sequence-indexed SAIL_843_G10 line segregating for a predicted insertion in At3g02870 was screened via PCR and At3g02870-specific primers to identify individuals homozygous for the insertion allele. Five such lines were identified. Two lines (KO-1 and KO-2) were used for further analysis (Fig. 7A). The site of the insertion was confirmed by sequencing to reside within exon 7; therefore, this mutant allele is predicted to be null. To determine whether the KO lines produced any VTC4 transcript, RT-PCR was conducted using VTC4 gene-specific primers that span exons 7 and 12. The PCR product from the VTC4 cDNA is expected to be 382 bp. A set of control primers that span exon 1 and exon 2 of a ferredoxin-nitrite reductase gene (At2g15620) are expected to amplify a 408-bp product from the corresponding cDNA. As seen in Fig. 7B, RT-PCR using the VTC4 gene-specific primers yielded the expected size product from WT as well as vtc4-1 cDNAs, whereas no product of the same size was amplified from cDNAs from the insertion lines KO-1 and KO-2. There is a small amount of product in these insertion lines, but it is slightly larger than that seen in WT and vtc4-1 and is most likely a nonspecific amplification product. The control primers yielded the expected size product from all the genotypes. Total ascorbate was determined in 2-week-old insertion mutant lines KO-1 and KO-2 along with WT and vtc4-1. As seen in Fig. 7C, both insertion mutant lines are deficient in ascorbate, with a deficiency quite similar to that of vtc4-1 grown under the same conditions. Furthermore, L-Gal-1-P phosphatase activity was reduced in the two KO lines. Similarly to vtc4-1, the extracts also hydrolyzed Man-1-P at a slightly lower rate than WT (Fig. 7D). To confirm genetically that the mutations that cause the ascorbate deficiencies in vtc4-1 and the insertion lines are allelic, genetic complementation analyses were conducted. The vtc4-1 line was used as the female to generate F1 progeny between vtc4-1 and KO-1 and between vtc4-1 and KO-2. DNA was isolated from pooled F1 individuals from each cross and the genotype confirmed by PCR. As seen in Fig. 8A, the WT and vtc4-1 individuals harbor noninsertion alleles, and the KO-1 and KO-2 lines harbor only insertion alleles, whereas the pooled F1 from each cross contain both alleles. Total ascorbate was determined in 2-week-old plants from each genotype (WT, vtc4-1, KO-1, KO-2, F1 (vtc4-1 xx KO-1), and F1 (vtc4-1 x KO-2). As seen in Fig. 7, A and C, the insertion lines do not genetically complement the ascorbate deficiency in vtc4-1, the F1s containing an insertion allele and a vtc4-1 allele are also ascorbate-deficient.
L-Gal-1-P phosphatase was recently purified and cloned by Laing et al. (23). However, they did not carry out a functional analysis, so the predicted role of this enzyme in ascorbate synthesis was not tested. Our results with the ascorbate-deficient A. thaliana mutant, vtc4-1, provide evidence that this enzyme is required for maximal ascorbate accumulation. First, VTC4 maps to the predicted L-Gal-1-P phosphatase gene (At3g02870), which has a point mutation predicted to alter an active site domain in the resultant enzyme. Second, vtc4-1 leaves have lower L-Gal-1-P phosphatase activity than WT. Third, an independent line with a T-DNA insertion in At3g02870 has low ascorbate, decreased L-Gal-1-P phosphatase activity, and is allelic to the vtc4-1 allele. Finally, in vivo labeling experiments with [3H]Man showed that vtc4-1 has perturbed L-Gal metabolism, as labeled L-galactosyl residues accumulated in polysaccharides in vtc4-1. Because GDP-L-Gal is the most likely source of these L-galactosyl residues, this observation suggests that the mutation increases its availability as a substrate for glycosyltransferases. A possible explanation for this is that L-Gal-1-P inhibits the enzyme that converts GDP-L-Gal to L-Gal-1-P. Alternatively, the accumulating L-Gal-1-P could be converted to GDP-L-Gal by a pyrophosphorylase. Additional evidence for feedback control of the pathway comes from analysis of A. thaliana plants with antisense suppression of L-Gal dehydrogenase. Not only does L-Gal accumulate as predicted (18), but gas chromatography-mass spectrometry analysis shows that Man (including Man-1-P and GDP-Man) also accumulates,6 suggesting that accumulation of L-Gal feeds back to the GDP-Man-3,5-epimerase step (Fig. 1). Finally, in the L-Fuc-deficient Arabidopsis mutant mur1 (defective in GDP-D-Man-4,6-dehydratase; see Ref. 42), L-Gal replaces L-Fuc in the cell wall xyloglucan (43) and rhamnogalacturonan II, a borate-binding pectin that is required for plant growth (44). As mammalian fucosyltransferase is able to utilize GDP-L-Gal as a substrate (45), it has been hypothesized that fucosyltransferase in mur1 is using GDP-L-Gal in the absence of GDP-L-Fuc (46). This implies that excess GDP-Man in mur1 is converted to GDP-L-Gal, which is then shunted into the cell wall and not into ascorbic acid, most likely due to the above-mentioned feedback control. As well as being required for ascorbate synthesis, an L-Gal residue occurs in side chain A of rhamnogalacturonan II (44). Therefore, further investigation of how GDP-L-Gal is partitioned between rhamnogalacturonan II and ascorbate synthesis would be fruitful given that reduced ascorbate synthesis increases L-Gal accumulation in polysaccharides in vtc4-1.
The Arabidopsis L-Gal-1-P phosphatase (At3g02870/VTC4) is annotated by the Arabidopsis genome data bases as a putative inositol/myo-inositol monophosphatase (IMPase; TAIR, TIGR, and MIPS). Four additional unlinked genes in the Arabidopsis genome have also been annotated as encoding putative IMPases (At1g31190, At4g05090, At4g39120, and At5g54390). As detailed above, it is clear that At3g02870/VTC4 encodes an enzyme with high specificity for L-Gal-1-P. Previously it was shown that this enzyme is 12 times more active against L-Gal-1-P than against myo-inositol-1-P (23). By using the Phylip phylogenetic inference software, the relationship between the predicted polypeptides encoded by these five IMPase-like genes and to mammalian IMPases was determined and is shown in Fig. 8. As expected, At3g02870 closely aligns with the A. deliciosa L-Gal-1-P phosphatase, and in fact, these two polypeptides share 79% amino acid identity. All five Arabidopsis gene products reside in the superfamily of metal-dependent phosphatases (HomoloGene cd01636). However, At5g54390 and At4g05090 both encode polypeptides with a predicted 3'-phosphoadenosine 5'-phosphate (PAP) phosphatase domain that places them into a different subgroup (cd1517) than that of the plant L-Gal-1-Pases and the IMPases that utilize mainly inositol monophosphate as a substrate (HomoloGene). Indeed, At5g54390 was previously identified as a HAL2-like gene (AtAHL) that encodes an enzyme shown experimentally to have sodium-sensitive PAP phosphatase activity (47). Two additional PAP phosphatase genes are present in the Arabidopsis genome (AtSAL1 and AtSAL2 (47)) but are annotated as encoding putative inositol polyphosphate 1-phosphatases (or 3'(2'), 5'-bisphosphate nucleotidases). Therefore, At4g05090 may be a fifth gene in a PAP phosphatase gene family. The two other IMPase-like genes (At1g31190 and At4g39120) encode polypeptides that are more closely related to each other than to the L-Gal-1-P phosphatases or to the PAP phosphatases, yet the predicted polypeptides both contain the conserved IMPase domain and may therefore have high specificity toward myo-inositol. Although it is true that these two polypeptides share only 2935% amino acid identity with three tomato enzymes shown to have IMPase activity, the activity of the tomato enzymes was only tested against inositol-1-P (48). Indeed, the tomato enzymes are much more closely aligned with the L-Gal-1-P phosphatases ( 72 to 76% identity) and, as also noted by Laing et al. (23), may therefore actually have much greater phosphatase activity against L-Gal-1-P than inositol-1-P. It is interesting to note that the mammalian IMPase 1 enzymes are more closely related to Arabidopsis L-Gal-1-P phosphatases than to the putative PAP phosphatases or the putative IMPases. The combined genetic and biochemical data presented here provide definitive in planta evidence for the role of L-Gal-1-P phosphatase in plant ascorbic acid biosynthesis. Although the radiolabeling experiments and the rapid conversion of L-Gal to ascorbate by plants suggest L-Gal-1-P is the substrate, it is also possible that the enzyme could work on L-Gul-1-P, thereby leading to ascorbate synthesis via L-gulonolactone (Fig. 1) (21). Importantly, the KO mutant still contains appreciable ascorbate, even though At3g02870 is not expressed. This suggests that other enzymes, such as the other IMPase homologues, can hydrolyze L-Gal-1-P and/or L-Gul-1-P in vivo or that the remaining ascorbate is synthesized via other pathways. Recently, evidence from transgenic manipulation has suggested pathways for ascorbate synthesis via D-galacturonic acid (49) and glucuronic acid (50). Interestingly, the recombinant enzyme hydrolyzes myo-inositol-1-P at 7% of the rate of L-Gal-1-P (23), suggesting it may have a role in ascorbate synthesis via glucuronate. At3g02870/VTC4 could therefore contribute to both the L-Gal and the myo-inositol pathways. Both the KO mutant and vtc4-1 have a similar decrease in L-Gal-1-P phosphatase activity. The sequence conservation of the substrate and Mg2+-binding residues shown by comparison with human inositol monophosphatase, and which includes the site of the P92L mutation in VTC4-1, suggests that the enzyme would has significantly reduced activity. This observation would explain the similarity in enzyme activity between vtc4-1 and the KO mutant. All the genes involved in synthesis of ascorbate from D-Man-1-P, with the exception of the step that converts GDP-L-Gal to L-Gal-1-P, have now been identified (Fig. 1). We are currently in the process of the functional characterization of the VTC2 and VTC3 genes. We predict that the identification of all the enzymes of the proposed D-Man/L-Gal pathway for ascorbate biosynthesis in plants (15) will soon be completed. This will provide a strong basis for understanding the control of ascorbate accumulation in plants and for investigating the contribution of pathways involving L-Gul (21) and uronic acid intermediates (49, 51).
* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 Supported by the National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education, and Extension Service Grant 1998-35100-12987 and a grant from the Dr. Nula McGann Drescher Affirmative Action/Diversity Leave Program.
2 Present address: Novartis Pharma AG, Biomarker Development, WKL-136.1.15, CH-4002 Basel, Switzerland.
3 Present address: Plymouth Marine Laboratory, Prospect Place, The Hoe, Plymouth PL1 3DH, UK. 4 Supported by the Biotechnology and Biological Sciences Research Council (UK) and Bio-Technical Resources (Manitowoc, WI). To whom correspondence should be addressed: School of Biosciences, Geoffrey Pope Bldg., University of Exeter, Stocker Road, Exeter EX4 4QD, UK. Tel.: 44-1392-263756; Fax: 44-1392-263700; E-mail: N.Smirnoff{at}exeter.ac.uk.
5 The abbreviations used are: ROS, reactive oxygen species; BC2, backcross 2; DTT, dithiothreitol; Fru, fructose; Fuc, fucose; Gal, galactose; Glc, glucose; Gul, gulose; IMPase, inositol monophosphatase; Man, mannose; WT, wild type; HPLC, high pressure liquid chromatography; KO, knock out; RT, reverse transcription; F, forward; R, reverse; PAP, 3'-phosphoadenosine 5'-phosphate.
6 S. Gatzek, N. Smirnoff, and O. Fiehn, unpublished data.
We thank both Jamie Brenchley and Brian Conlin for their contributions to the mapping of VTC4. We are indebted to Prof. J. Thiem (University of Hamburg, Germany) for the gift of L-Gal-1-P.
This article has been cited by other articles:
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||